Immuneering Corporation (IMRX) Net margin 2020–2022
Immuneering Corporation (IMRX) net profit margin by fiscal year — reported net income divided by reported revenue.
-15937.3%FY2022 · since FY2020: -737.2% → -15937.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -15937.3% | -14325.0 pp |
| FY2021 | -1612.3% | -875.2 pp |
| FY2020 | -737.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IMRX financial trends
IMRX RevenueIMRX Net incomeIMRX Gross profitIMRX Gross marginIMRX Operating incomeIMRX Operating marginIMRX Operating cash flowIMRX Free cash flowIMRX Capital expendituresIMRX Return on equityIMRX Stock buybacksIMRX Dividends paidIMRX Total assetsIMRX Total liabilitiesIMRX Shareholders’ equityIMRX overview →